Oil’s Iran Cliffhanger: What To Know And What To Expect
- Analysis
- Barani Krishnan
- 32
Name | Last | Prev. | High | Low | Chg. % | Vol. | Time | Price | |
---|---|---|---|---|---|---|---|---|---|
GSK GSK plc | 1,534.00 | 1,500.50 | 1,535.50 | 1,497.00 | +2.23% | 8.91M | 1,534.00+2.23% | 08/03 | |
NOVN Novartis AG | 100.92 | 99.47 | 101.12 | 98.69 | +1.46% | 3.97M | 100.92+1.46% | 08/03 | |
NOVOb Novo Nordisk A/S Class B | 597.60 | 612.40 | 622.60 | 594.70 | -2.42% | 3.5M | 597.60-2.42% | 08/03 | |
AZN AstraZeneca PLC | 12,072.00 | 12,028.00 | 12,072.00 | 11,914.00 | +0.37% | 3.11M | 12,072.00+0.37% | 08/03 | |
SASY Sanofi SA | 109.62 | 109.62 | 110.06 | 108.46 | 0.00% | 2.59M | 109.620.00% | 08/03 |
Name | Price |
---|---|
GSK GSK plc | 1,534.00+33.50+2.23% |
EMEIS Emeis | 12.234+0.2160+1.83% |
NSISb Novozymes B | 412.20+6.2+1.53% |
NOVN Novartis | 100.92+1.45+1.46% |
ROG Roche Holding Participation | 307.00+4.30+1.42% |
Name | Price |
---|---|
INDV Indivior | 727.50-34.50-4.53% |
MRCG Merck | 135.50-5.80-4.10% |
GXId Gerresheimer AG | 79.93-3.33-4.00% |
SOBIV Swedish Orphan Biovitrum | 294.40-7.40-2.45% |
NOVOb Novo Nordisk B | 597.60-14.8-2.42% |